NCT06371144

Brief Summary

ABSTRACT BACKGROUND: Labor pain is one of the most excruciating pain experienced by women. It affects maternal psychology and the course of labor causing apprehension, anxiety, and stress. Therefore there is a need for a safe and effective analgesic with minimal maternal and fetal side effects like intravenous paracetamol which has been shown to have great analgesic effect in labour with minimal maternal and neonatal side effects. OBJECTIVE: To compare intravenous paracetamol versus intramuscular tramadol as labour analgesia and to evaluate the incidence of side effects on mother and baby of both drugs. METHOD: This would be a hospital based randomized controlled trial comparing intravenous paracetamol to intramuscular tramadol as labour analgesia in pregnant women in active phase of labour in the department of obstetrics and gynecology at Alex-Ekwueme Federal University Teaching Hospital and St. Patrick Mile 4 hospital, Abakaliki. A total of 194 pregnant women in active phase of labour will be included in study after fulfilling the inclusion criteria. These women will be divided into 2 groups of 97 each. Group A will receive a 100ml intravenous infusion containing 1000mg of paracetamol single dose over 15min. Group B: will receive intramuscular tramadol hydrochloride 100mg single dose. Pain intensity of women with both drugs will be noted before administration of drug, one hour, two hours and three hours after administration of drug using the visual analog scale. Perinatal outcome will also be recorded. 10 ANALYSIS AND RESULTS: Data will be collated, tabulated and then statistically analyzed using Statistical Package for Social Science (IBM SPSS) software (version 24, Chicago II, USA). Continuous variables will be presented as mean and standard deviation (Mean ± 2SD) or median and range as appropriate, while categorical variables will be presented as frequencies and percentages. Chi-square test( or Fisher's exact test where applicable) will be used for comparison between groups for categorical variables while student t test or Mann-Whitney U test will be used for comparison between groups for continuous variables KEYWORDS Labour analgesia, intravenous paracetamol, intramuscular tramadol, visual analog scale, neonate, side effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
194

participants targeted

Target at P75+ for phase_2 pain

Timeline
Completed

Started Jun 2022

Shorter than P25 for phase_2 pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 3, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 10, 2022

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

October 16, 2023

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

3 months

First QC Date

October 16, 2023

Last Update Submit

April 14, 2024

Conditions

Keywords

Labour analgesia, paracetamol, tramadol

Outcome Measures

Primary Outcomes (1)

  • Mean pain score

    A standardized scale will be used to asses the mean pain score

    4hours following administration of each agent

Study Arms (2)

Paracetamol group

EXPERIMENTAL

Receive intravenous paracetamol intrapartum as labour analgesia

Drug: Paracetamol

Tramadol group

ACTIVE COMPARATOR

Receive intramuscular tramadol intrapartum as labour analgesia

Drug: Paracetamol

Interventions

Analgestic

Also known as: Acetaminophen
Paracetamol groupTramadol group

Eligibility Criteria

Age15 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen in labour
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant women carrying live singleton fetuses at 37-42 weeks' gestational age.
  • Pregnant women in active phase of labour; cervical dilatation ≥ 4cm
  • Spontaneous onset of labour.
  • Singleton pregnancy with vertex presentation

You may not qualify if:

  • Women with clinical evidence of cephalopelvic disproportion
  • Malpresentation
  • Multiple pregnancy
  • Previously scarred uterus (post myomectomy, post caesarean)
  • Preterm labour
  • Induced labour
  • Antepartum hemorrhage
  • Pregnancy induced hypertension
  • History of known allergy to tramadol and paracetamol or opioids
  • History of medical disorders
  • Fetal distress
  • Intrauterine fetal death
  • Refusal to give consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AEFUTHA

Abakaliki, Ebonyi State, 234, Nigeria

Location

MeSH Terms

Conditions

Pain

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • OGBO DR UZOMA, MBBS

    Alex Ekwueme Federal University Teaching Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Double blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: To compare intravenous paracetamol versus intramuscular tramadol as labour analgesia and to evaluate the incidence of side effects on mother and baby of both drugs
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

October 16, 2023

First Posted

April 17, 2024

Study Start

June 3, 2022

Primary Completion

September 10, 2022

Study Completion

September 10, 2022

Last Updated

April 17, 2024

Record last verified: 2024-04

Locations